Document Detail


Large-cell neuroendocrine carcinoma of the uterine cervix complicating pregnancy.
MedLine Citation:
PMID:  19197101     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Large-cell neuroendocrine cervical carcinoma is a rare and aggressive cancer that tends to spread and recur early despite intensive multimodal treatment. The optimal mode of therapy is still controversial and management during pregnancy is challenging because foetal well-being must also be considered. We report a patient with clinically stage IIB large-cell neuroendocrine cervical carcinoma who presented with a cervical polyp and vaginal bleeding at 18 weeks of pregnancy. The patient received concurrent chemotherapy and radiation after termination of pregnancy and remained in complete remission 21 months after completion of treatment.
Authors:
William W H Li; T N Yau; Carmen W L Leung; W M Pong; May Y M Chan
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Hong Kong medical journal = Xianggang yi xue za zhi / Hong Kong Academy of Medicine     Volume:  15     ISSN:  1024-2708     ISO Abbreviation:  Hong Kong Med J     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-02-06     Completed Date:  2009-05-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9512509     Medline TA:  Hong Kong Med J     Country:  China    
Other Details:
Languages:  eng     Pagination:  69-72     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynaecology, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong. liwh2@yahoo.com.hk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortion, Induced
Adult
Antineoplastic Agents, Phytogenic / administration & dosage
Carcinoma, Large Cell* / drug therapy,  pathology,  radiotherapy
Carcinoma, Neuroendocrine* / drug therapy,  pathology,  radiotherapy
Cervix Uteri / pathology
Etoposide / administration & dosage
Female
Humans
Polyps / pathology
Pregnancy
Pregnancy Complications, Neoplastic* / drug therapy,  pathology,  radiotherapy
Treatment Outcome
Uterine Cervical Neoplasms* / drug therapy,  pathology,  radiotherapy
Chemical
Reg. No./Substance:
0/Antineoplastic Agents, Phytogenic; 33419-42-0/Etoposide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of closed controlled subcutaneous drainage to manage chronic lower limb oedema in patients with ...
Next Document:  Extremely low birthweight infants in Iceland 1991-95. Risk factors for perinatal and neonatal death